Southern Cross Gold Ltd (SXG) ORDINARY FULLY PAID |
Materials |
- |
SXG Mines and Wines Technical Presentation - September 2024
|
6 Sep 2024 8:54AM |
$2.740 |
$3.450 |
risen by
25.91%
|
|
Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$22 |
Lumos Successfully Completes Institutional Entitlement Offer
|
6 Sep 2024 8:54AM |
$0.046 |
$0.030 |
fallen by
34.78%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited successfully completes the institutional component of its $10 million equity raising.
- The institutional component raised approximately $3.1 million from institutional and sophisticated investors.
- The retail component is expected to raise approximately $6.9 million.
- New shares are issued at $0.038 per share and will rank equally with existing shares.
- Funds will be used for the FebriDx CLIA waiver trial, product development, sales and marketing, working capital, and offer costs.
- The retail offer opens on 11 September 2024 and closes on 2 October 2024.
- The retail offer is underwritten by Bell Potter, with sub-underwriting from Tenmile and Ryder Capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$303 |
First sales of Striate in major new market of Canada
|
6 Sep 2024 8:53AM |
$0.390 |
$1.245 |
risen by
219.23%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell Limited recorded first sales of Striate+ in Canada.
- BioHorizons is Orthocell’s exclusive global distribution partner.
- Regulatory approval from Health Canada was received in early July.
- The Canadian market for Striate+ is estimated to be AU$60 million.
- Striate+ is gaining traction in the US, EU, UK, and Australia.
- The product has a 98.6% success rate from post-market clinical studies.
- Orthocell anticipates regulatory approvals in Brazil and Singapore within 6-12 months.
- The company reported record revenue of $6.76 million in FY24, up 30.76% YoY.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
TG Metals Limited (TG6) ORDINARY FULLY PAID |
Materials |
$9 |
High Grade Lithium Mineralisation at Burmeister Continues
|
6 Sep 2024 8:53AM |
$0.120 |
$0.115 |
fallen by
4.17%
|
|
TG6 - Price-sensitive ASX Announcement
Full Release
Key Points
- TG Metals Limited reported high-grade lithium mineralization at the Burmeister deposit within the Lake Johnston Project in Western Australia.
- Assay results from 28 drill holes (totaling 4,722m) confirmed multiple intersections of spodumene-bearing pegmatites with high Li2O grades.
- Highlighted results include 8.0m @ 1.92% Li2O from 106.0m, 9.0m @ 1.38% Li2O from 117.0m, and 14.0m @ 1.55% Li2O from 240.0m.
- The Burmeister pegmatites show consistent high-grade and continuity, with mineralization remaining open to the west and north.
- Seismic data reinforced the modelled emplacement style for Burmeister pegmatites but were limited in depth extension detection due to mafic-ultramafic contacts.
- Jaegermeister prospect also shows promising results, suggesting a size potential similar to or larger than Burmeister.
- Infill drilling at Burmeister was affected by seasonal wet weather, and future drilling will target the southern section once conditions improve.
- Metallurgical test work is nearing completion, with a focus on ore sorting technology, dense media separation, and flotation technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Jumbo Interactive Limited (JIN) ORDINARY FULLY PAID |
Consumer Discretionary |
$603 |
Update - Notification of buy-back - JIN
|
6 Sep 2024 8:53AM |
$13.500 |
$9.650 |
fallen by
28.52%
|
|
Hancock & Gore Ltd (HNG) ORDINARY FULLY PAID |
Industrials |
$137 |
Notice of General Meeting and Proxy Form
|
6 Sep 2024 8:52AM |
$0.320 |
$0.265 |
fallen by
17.19%
|
|
CD Private Equity Fund I (CD1) ORDINARY UNITS FULLY PAID |
Financials |
$20 |
CD Fund Series - Half Year Update Presentation
|
6 Sep 2024 8:51AM |
$0.635 |
$0.550 |
fallen by
13.39%
|
|
CD Private Equity Fund II (CD2) ORDINARY UNITS FULLY PAID |
Financials |
$40 |
CD Fund Series - Half Year Update Presentation
|
6 Sep 2024 8:51AM |
$0.900 |
$0.760 |
fallen by
15.56%
|
|
CD Private Equity Fund III (CD3) ORDINARY UNITS FULLY PAID |
Financials |
$86 |
CD Fund Series - Half Year Update Presentation
|
6 Sep 2024 8:51AM |
$1.235 |
$1.200 |
fallen by
2.83%
|
|
Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$1,101 |
PRU: Perseus increases investment in Predictive to 19.9%
|
6 Sep 2024 8:50AM |
$0.220 |
$0.420 |
risen by
90.91%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Perseus Mining Limited increased its stake in Predictive Discovery Limited to 19.9%
- Perseus used proceeds from unwinding a previous cash settled equity swap position in Predictive to fund the acquisition
- Details of Perseus's interests in Predictive will be provided in a Form 604 Notice of Change of Substantial Interest
- Perseus has no current intention to acquire control or make a takeover offer for Predictive
- The announcement was authorized by Jeff Quartermaine, Managing Director and CEO of Perseus
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$5,258 |
Perseus increases investment in Predictive to 19.9%
|
6 Sep 2024 8:50AM |
$2.450 |
$3.860 |
risen by
57.55%
|
|
PRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Perseus Mining Limited increased its relevant interest in Predictive Discovery Limited to 19.9%.
- Perseus funded the acquisition by unwinding its cash settled equity swap position in Predictive.
- Further details will be provided in a Form 604 Notice of Change of Substantial Interest.
- Perseus has no current intention to acquire control or make a takeover offer for Predictive.
- Announcement authorized by Jeff Quartermaine, Managing Director and CEO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,420 |
Notification of cessation of securities - QAN
|
6 Sep 2024 8:50AM |
$6.840 |
$10.190 |
risen by
48.98%
|
|
AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$345 |
Update - Notification of buy-back - AMH
|
6 Sep 2024 8:46AM |
$1.120 |
$1.095 |
fallen by
2.23%
|
|
NobleOak Life Limited (NOL) ORDINARY FULLY PAID |
Financials |
$148 |
2024 AGM and closing date for director nominations
|
6 Sep 2024 8:45AM |
$1.490 |
$1.600 |
risen by
7.38%
|
|
Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$22 |
Change of Director's Interest Notice - Damian Banks
|
6 Sep 2024 8:43AM |
$0.455 |
$0.395 |
fallen by
13.19%
|
|
Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$6 |
Company Presentation
|
6 Sep 2024 8:43AM |
$0.320 |
$0.087 |
fallen by
72.81%
|
|
Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$5 |
Investor Webinar Presentation 06 Sep 24
|
6 Sep 2024 8:42AM |
$0.046 |
$0.020 |
fallen by
56.52%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Development of two naturally derived active ingredients, Flavocide and Qcide
- Regulatory progress with APVMA for Flavocide
- Collaboration with Envu for mosquito management
- Successful pilot-scale production by Rallis India
- Targeting five large global markets: crop protection, public health vector control, animal health, consumer applications, and grain storage
- Multiple commercial partnerships providing various market paths
- Focus on overcoming insect resistance with a novel mode of action
- Strategic priorities include product development, commercial validation, and efficient use of capital
- Company aims to meet growing demand for safer and more natural insect control solutions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
PlaySide Studios Limited (PLY) ORDINARY FULLY PAID |
Communication Services |
$76 |
Change of Director's Interest Notice
|
6 Sep 2024 8:42AM |
$0.550 |
$0.185 |
fallen by
66.36%
|
|
EnviroSuite Limited (EVS) ORDINARY FULLY PAID |
Information Technology |
$120 |
Becoming a substantial holder
|
6 Sep 2024 8:42AM |
$0.060 |
$0.083 |
risen by
38.33%
|
|
VanEck MSCI International Sustainable Equity ETF (ESGI) |
Financials |
$215 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$34.830 |
$37.930 |
risen by
8.90%
|
|
VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$146 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$19.370 |
$18.630 |
fallen by
3.82%
|
|
VanEck Global Healthcare Leaders ETF (HLTH) |
Financials |
$50 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$11.580 |
$11.370 |
fallen by
1.81%
|
|
VanEck MSCI Multifactor Emerging Markets Equity ETF (EMKT) |
Financials |
$244 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$23.980 |
$28.390 |
risen by
18.39%
|
|
VanEck Morningstar International Wide Moat ETF (GOAT) |
Financials |
$53 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$26.980 |
$28.410 |
risen by
5.30%
|
|
VanEck 1-3 Month US Treasury Bond ETF (TBIL) |
Financials |
$144 |
Issued Units Outstanding as at 31 August 2024
|
6 Sep 2024 8:41AM |
$49.790 |
$51.670 |
risen by
3.78%
|
|